Reuters: Health
AstraZeneca Plc said on Monday the U.S. Food and Drug Administration (FDA) had granted fast track designation for the development of its diabetes drug Farxiga to reduce the risk of deadly heart attacks in some patients.
AstraZeneca's Farxiga granted fast track status for heart failure treatment
AstraZeneca's Farxiga granted fast track status for heart failure treatment
Reuters: Health
AstraZeneca Plc said on Monday the U.S. Food and Drug Administration (FDA) had granted fast track designation for the development of its diabetes drug Farxiga to reduce the risk of deadly heart attacks in some patients.
Reuters: Health
AstraZeneca Plc said on Monday the U.S. Food and Drug Administration (FDA) had granted fast track designation for the development of its diabetes drug Farxiga to reduce the risk of deadly heart attacks in some patients.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment